We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
(+100,205%)
Cap. Flow
-$417M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$89.3M |
| 2 |
Keysight
KEYS
|
+$86M |
| 3 |
Nike
NKE
|
+$78.3M |
| 4 |
Amphenol
APH
|
+$76.5M |
| 5 |
Comcast
CMCSA
|
+$72.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celanese
CE
|
+$108M |
| 2 |
Monster Beverage
MNST
|
+$97.8M |
| 3 |
Starbucks
SBUX
|
+$79.7M |
| 4 |
Texas Instruments
TXN
|
+$67.3M |
| 5 |
Centene
CNC
|
+$64.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.83% |
| 2 | Financials | 13.42% |
| 3 | Healthcare | 13.25% |
| 4 | Industrials | 9.77% |
| 5 | Consumer Discretionary | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Avnet
AVT
$7.11B
| $314K | ﹤0.01% |
7,400
-808
| -10% | -$33.3K |
|
902
Lumentum
LITE
$50.6B
| $312K | ﹤0.01% |
3,935
+3,894
| +9,498% | +$255K |
|
|
BAND
903
Bandwidth Inc
BAND
$1.67B
| $309K | ﹤0.01% |
4,829
+2,869
| +146% | +$166K |
|
|
HSBC.PRA
904
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
| $309K | ﹤0.01% |
11,525
| – | – |
|
905
SouthState Bank Corp
SSB
$10.3B
| $308K | ﹤0.01% |
3,560
| – | – |
|
|
BF
906
DELISTED
BASF AKTIENGESELLT ADS(RP1 ORD
BF
| $302K | ﹤0.01% |
16,008
-283
| -2% | -$5.34K |
|
907
Invesco Dorsey Wright Technology Momentum ETF
PTF
$554M
| $301K | ﹤0.01% |
11,724
| – | – |
|
|
DAI
908
DELISTED
DAIMLER AG
DAI
| $301K | ﹤0.01% |
5,528
+759
| +16% | +$41.3K |
|
909
eHealth
EHTH
$43.2M
| $298K | ﹤0.01% |
3,103
+191
| +7% | +$14.8K |
|
910
State Street SPDR Dow Jones REIT ETF
RWR
$1.92B
| $298K | ﹤0.01% |
2,924
| – | – |
|
911
Royal Bank of Canada
RY
$295B
| $295K | ﹤0.01% |
3,730
-191
| -5% | -$15.4K |
|
912
Icon
ICLR
$13.9B
| $292K | ﹤0.01% |
1,698
+258
| +18% | +$39.8K |
|
|
AGR
913
DELISTED
Avangrid, Inc.
AGR
| $291K | ﹤0.01% |
5,703
+5,011
| +724% | +$249K |
|
914
A.O. Smith
AOS
$8.78B
| $289K | ﹤0.01% |
6,093
-87,374
| -93% | -$4.24M |
|
915
Scotiabank
BNS
$108B
| $289K | ﹤0.01% |
5,136
+452
| +10% | +$25.7K |
|
916
Kinsale Capital Group
KNSL
$8.4B
| $289K | ﹤0.01% |
2,847
-24
| -0.8% | -$2.39K |
|
917
uniQure
QURE
$2.45B
| $289K | ﹤0.01% |
4,041
+181
| +5% | +$9.94K |
|
918
NETSCOUT
NTCT
$2.9B
| $288K | ﹤0.01% |
11,987
| – | – |
|
919
W.R. Berkley
WRB
$28.4B
| $287K | ﹤0.01% |
9,389
-711
| -7% | -$21.9K |
|
920
Trade Desk
TTD
$8.86B
| $286K | ﹤0.01% |
11,060
-40
| -0.4% | -$900 |
|
921
Autodesk
ADSK
$50.4B
| $283K | ﹤0.01% |
1,547
-279
| -15% | -$45.2K |
|
|
ETRN
922
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $283K | ﹤0.01% |
21,267
-7,220
| -25% | -$89.6K |
|
923
Albany International
AIN
$2.16B
| $282K | ﹤0.01% |
3,723
-3,471
| -48% | -$288K |
|
924
Strategic Education
STRA
$1.85B
| $282K | ﹤0.01% |
1,779
+70
| +4% | +$9.72K |
|
925
Steven Madden
SHOO
$3.23B
| $281K | ﹤0.01% |
6,553
-8,956
| -58% | -$362K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
- Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
- Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
- Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
- Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
- Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
- Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.
Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.